PDL BioPharma to Announce Third Quarter Financial Results on November 6, 2018
Conference Call Details
To access the live conference call via phone, please dial (844) 535-4071 from
To access the live and subsequently archived webcast of the conference call, go to the Company's website and go to "Events & Presentations." Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary.
We seek to provide a significant return for our stockholders by acquiring and managing a portfolio of companies, products, royalty agreements and debt facilities in the biotechnology, pharmaceutical and medical device industries. In 2012, we began providing alternative sources of capital through royalty monetizations and debt facilities, and in 2016, we began acquiring commercial-stage products and launching specialized companies dedicated to the commercialization of these products. To date, we have consummated seventeen of such transactions, of which nine are active and outstanding. We have one debt transaction outstanding, representing deployed capital of
View original content to download multimedia:http://www.prnewswire.com/news-releases/pdl-biopharma-to-announce-third-quarter-financial-results-on-november-6-2018-300741520.html
PDL BioPharma, Inc., Peter Garcia, CFO, 775-832-8500, Peter.firstname.lastname@example.org; LHA Investor Relations, Jody Cain, SVP, 310-691-7100, email@example.com